Ameritas Investment Partners’s Medifast MED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-1,067
| Closed | -$10.9K | – | 3273 |
|
|
2026
Q1 | $10.9K | Hold |
1,067
| – | – | ﹤0.01% | 2841 |
|
|
2025
Q4 | $11.4K | Hold |
1,067
| – | – | ﹤0.01% | 2869 |
|
|
2025
Q3 | $14.6K | Hold |
1,067
| – | – | ﹤0.01% | 2816 |
|
|
2025
Q2 | $15K | Hold |
1,067
| – | – | ﹤0.01% | 2796 |
|
|
2025
Q1 | $14.4K | Hold |
1,067
| – | – | ﹤0.01% | 2682 |
|
|
2024
Q4 | $18.8K | Hold |
1,067
| – | – | ﹤0.01% | 2662 |
|
|
2024
Q3 | $20.4K | Hold |
1,067
| – | – | ﹤0.01% | 2649 |
|
|
2024
Q2 | $23.3K | Hold |
1,067
| – | – | ﹤0.01% | 2552 |
|
|
2024
Q1 | $40.9K | Hold |
1,067
| – | – | ﹤0.01% | 2261 |
|
|
2023
Q4 | $71.7K | Hold |
1,067
| – | – | ﹤0.01% | 1946 |
|
|
2023
Q3 | $79.9K | Buy |
1,067
+215
| +25% | +$19.1K | ﹤0.01% | 1809 |
|
|
2023
Q2 | $78.5K | Hold |
852
| – | – | ﹤0.01% | 1756 |
|
|
2023
Q1 | $88.3K | Hold |
852
| – | – | ﹤0.01% | 1615 |
|
|
2022
Q4 | $102K | Hold |
852
| – | – | ﹤0.01% | 1591 |
|
|
2022
Q3 | $92K | Hold |
852
| – | – | ﹤0.01% | 1550 |
|
|
2022
Q2 | $153K | Sell |
852
-67
| -7% | -$12K | 0.01% | 1225 |
|
|
2022
Q1 | $157K | Hold |
919
| – | – | 0.01% | 1340 |
|
|
2021
Q4 | $192K | Hold |
919
| – | – | 0.01% | 1258 |
|
|
2021
Q3 | $177K | Hold |
919
| – | – | 0.01% | 1302 |
|
|
2021
Q2 | $260K | Hold |
919
| – | – | 0.01% | 1060 |
|
|
2021
Q1 | $195K | Sell |
919
-56
| -6% | -$13.4K | 0.01% | 1227 |
|
|
2020
Q4 | $191K | Hold |
975
| – | – | 0.01% | 1188 |
|
|
2020
Q3 | $160K | Hold |
975
| – | – | 0.01% | 1153 |
|
|
2020
Q2 | $135K | Hold |
975
| – | – | 0.01% | 1236 |
|
|
2020
Q1 | $61K | Hold |
975
| – | – | ﹤0.01% | 1547 |
|
|
2019
Q4 | $107K | Hold |
975
| – | – | ﹤0.01% | 1475 |
|
|
2019
Q3 | $101K | Hold |
975
| – | – | ﹤0.01% | 1464 |
|
|
2019
Q2 | $125K | Hold |
975
| – | – | 0.01% | 1354 |
|
|
2019
Q1 | $124K | Hold |
975
| – | – | 0.01% | 1346 |
|
|
2018
Q4 | $122K | Hold |
975
| – | – | 0.01% | 1252 |
|
|
2018
Q3 | $216K | Hold |
975
| – | – | 0.01% | 1037 |
|
|
2018
Q2 | $156K | Buy |
975
+137
| +16% | +$17.5K | 0.01% | 1230 |
|
|
2018
Q1 | $78K | Hold |
838
| – | – | ﹤0.01% | 1644 |
|
|
2017
Q4 | $59K | Hold |
838
| – | – | ﹤0.01% | 1838 |
|
|
2017
Q3 | $47K | Hold |
838
| – | – | ﹤0.01% | 1934 |
|
|
2017
Q2 | $35K | Hold |
838
| – | – | ﹤0.01% | 2124 |
|
|
2017
Q1 | $37K | Buy |
+838
| New | +$36.1K | ﹤0.01% | 2035 |
|
Other funds holding MED
SCP
Ameritas Investment Partners's MED Position: Q2 2026 in Review
Ameritas Investment Partners sold out of Medifast (MED) in Q2 2026, closing a stake of 1,067 shares — an estimated $10.9K sold.
Ameritas Investment Partners first reported a position in MED in Q1 2017 and held it in 37 quarters. The position peaked at $260K in Q2 2021. 112 funds tracked by Wall St. Rank hold MED as of Q2 2026.
- Ameritas Investment Partners reported no remaining Medifast position as of Q2 2026 after selling out during the quarter.
- Ameritas Investment Partners sold 1,067 Medifast shares in Q2 2026, an estimated $10.9K.
- Ameritas Investment Partners first reported a position in Medifast in Q1 2017 and held it in 37 quarters.
- Ameritas Investment Partners's Medifast position peaked at $260K in Q2 2021.
- 112 funds tracked by Wall St. Rank held Medifast as of Q2 2026.
Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.